Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120
- Written by PR Newswire
Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research
FREMONT, Calif., March 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce the launch of the NULISAseq Mouse Panel 120, an...